InnovHeart

InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a medical device designed to treat patients suffering from severe mitral valve disease. The technology includes a proprietary bioprosthesis capable of trans-septal implantation to provide a less invasive solution for heart valve therapy. The company conducts clinical trials to validate the hemodynamic results and safety of its transcatheter platforms in elderly and high-risk patient populations.